Zobrazeno 1 - 10
of 56
pro vyhledávání: '"O. W. Isom"'
Autor:
O. W. Isom, Dany Bouraad, Leonard N. Girardi, Karl H. Krieger, Joseph A. Franciosa, Jeffrey S. Borer, Jacek J. Preibisz, Lindsey Forur, Clare Hochreiter, Phyllis G. Supino
Publikováno v:
Journal of Cardiac Failure. 15:267-277
Background Health-related quality of life (HQOL) enhancement is a major objective of valvular surgery (VS), but assessments have been limited primarily to generic measures that may not be optimally responsive to intervention. Disease-specific instrum
Autor:
C A, Mack, C J, Magovern, K T, Budenbender, S R, Patel, E A, Schwarz, P, Zanzonico, B, Ferris, T, Sanborn, P, Isom, O W, Isom, R G, Crystal, T K, Rosengart
Publikováno v:
Journal of Vascular Surgery. 27:699-709
Purpose: Vascular endothelial growth factor (VEGF) is a potent stimulator of angiogenesis, and transgene expression from adenovirus vectors can provide in vivo delivery of proteins. On the basis of this knowledge, we hypothesized that local administr
Autor:
L Y, Lee, S R, Patel, N R, Hackett, C A, Mack, D R, Polce, T, El-Sawy, R, Hachamovitch, P, Zanzonico, T A, Sanborn, M, Parikh, O W, Isom, R G, Crystal, T K, Rosengart
Publikováno v:
The Annals of thoracic surgery. 69(1)
Adenovirus (Ad) vector-mediated gene therapy strategies have emerged as promising modalities for the "biological revascularization" of tissues. We hypothesized that direct intramyocardial, as opposed to intracoronary, administration of an Ad vector c
Publikováno v:
Proceedings of the Association of American Physicians. 111(6)
Our objective was to determine the predictors of cardiac complications among a cohort of elective coronary artery bypass graft (CABG) surgery patients and to determine the relationship of such complications to subsequent quality of life and symptoms.
Autor:
C A, Mack, C J, Magovern, R T, Hahn, T, Sanborn, L, Lanning, W, Ko, O W, Isom, T K, Rosengart
Publikováno v:
Circulation. 96
Transmyocardial revascularization (TMR) has emerged as a promising treatment for ischemic heart disease in patients who are not candidates for coronary bypass surgery or angioplasty. Controversy exists, however, as to whether the use of laser energy
Autor:
W C, Fang, R E, Helm, K H, Krieger, T K, Rosengart, W J, DuBois, C, Sason, M L, Lesser, O W, Isom, J P, Gold
Publikováno v:
Circulation. 96
The hematocrit on cardiopulmonary bypass (CPB) frequently falls to a low level during many cardiac surgical procedures. This study was designed to explore the impact on mortality of minimum hematocrit level achieved during the CPB after coronary arte
Publikováno v:
Journal of the American College of Surgeons. 184(6)
Blood transfusion persists as an important risk of open heart operations despite the recent introduction of a variety of new pharmacologic agents and blood conservation techniques as independent therapies. A comprehensive multimodality blood conserva
Publikováno v:
The Journal of cardiovascular surgery. 37(6)
The use of hypothermia during cardiopulmonary bypass and cardioplegia poses a special problem in patients with cold-reactive hemagglutination. This is a case report of a successful aortic valve replacement on a patient with severe aortic valve stenos
Autor:
C J, Magovern, C A, Mack, J, Zhang, R T, Hahn, W, Ko, O W, Isom, R G, Crystal, T K, Rosengart
Publikováno v:
The Annals of thoracic surgery. 62(2)
Direct myocardial gene transfer is a mordality that involves the introduction of genetic information into myocardial tissue to achieve a therapeutic effect. This study was designed to characterize the temporal and spatial limits of gene expression an
Publikováno v:
Best practices and benchmarking in healthcare : a practical journal for clinical and management application. 1(1)
A multidisciplinary project was undertaken at The New York Hospital-Cornell Medical Center to develop critical pathways for open-heart surgery to help reduce cost, shorten hospital length of stay (LOS), and streamline patient care.A critical pathway